XIMITOR

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameXIMITOR
Drug Alias NameXIMITOR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 3 antagonists
TargetsToll like receptor 3
Therapy Area/IndicationsInflammationAutoimmune DiseasesPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRiboxx Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRiboxx Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A